Richard A. Feelders
- Endocrinology, Diabetes and Metabolism top 0.05%
- Pituitary Gland Disorders and Treatments 147
- Adrenal Hormones and Disorders 73
- Growth Hormone and Insulin-like Growth Factors 48
- Neurology top 0.2%
- Neuroblastoma Research and Treatments 54
- Epidemiology top 0.2%
- Neuroendocrine Tumor Research Advances 85
- Oncology top 0.5%
- Lung Cancer Research Studies 42
- Behavioral Neuroscience top 1%
-
- Adrenal and Paraganglionic Tumors 86
-
- Cancer, Hypoxia, and Metabolism 38
- Co-authors
- Wouter W. de HerderLeo J. HoflandDik J. KwekkeboomSteven W. J. LambertsCasper H.J. van EijckEric P. KrenningLynnette K. NiemanBoen L.R. Kam
- Partner nations
- NetherlandsUnited StatesItaly
In The Last Decade
Richard A. Feelders
257 papers receiving 12.2k citations
Hit Papers
Peers
Comparison fields: 5 of 150
- Endocrinology, Diabetes and Metabolism 6.5k
- Neurology 3.3k
- Epidemiology 4.9k
- Oncology 3.4k
- Behavioral Neuroscience 335
Countries citing papers authored by Richard A. Feelders
This map shows the geographic impact of Richard A. Feelders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard A. Feelders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard A. Feelders more than expected).
Fields of papers citing papers by Richard A. Feelders
This network shows the impact of papers produced by Richard A. Feelders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard A. Feelders. The network helps show where Richard A. Feelders may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Richard A. Feelders, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 7 | |
| 8 | 2024 | 6 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 11 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 4 | |
| 13 | 2022 | 66 | |
| 14 | 2022 | 24 | |
| 15 | Aberrant tryptophan metabolism in stromal cells is associated with mesenteric fibrosis ismall intestinal neuroendocrine tumors | 2022 | 4 |
| 16 | 2022 | 13 | |
| 17 | 2021 | 40 | |
| 18 | 2019 | 52 | |
| 19 | 2009 | 171 | |
| 20 | Treatment With the Radiolabeled Somatostatin Analog [ 177 Lu-DOTA 0 ,Tyr 3 ]Octreotate: Toxicity, Efficacy, and Survivalbreakdown → | 2008 | 1093 |
About Richard A. Feelders
Richard A. Feelders is a scholar working on Endocrinology, Diabetes and Metabolism, Neurology and Epidemiology, having authored 272 papers that have together received 12.5k indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (147 papers), Adrenal and Paraganglionic Tumors (86 papers), Neuroendocrine Tumor Research Advances (85 papers), Adrenal Hormones and Disorders (73 papers), Neuroblastoma Research and Treatments (54 papers), Growth Hormone and Insulin-like Growth Factors (48 papers), Lung Cancer Research Studies (42 papers) and Cancer, Hypoxia, and Metabolism (38 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (6.5k citations), Neurology (3.3k citations) and Epidemiology (4.9k citations). Richard A. Feelders has collaborated with scholars based in Netherlands, United States and Italy. Frequent co-authors include Wouter W. de Herder, Leo J. Hofland, Dik J. Kwekkeboom, Steven W. J. Lamberts, Casper H.J. van Eijck, Eric P. Krenning, Lynnette K. Nieman, Boen L.R. Kam, André Lacroix and Maarten O. van Aken. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.